Structure

Physi-Chem Properties

Molecular Weight:  514.26
Volume:  527.781
LogP:  2.698
LogD:  1.728
LogS:  -4.401
# Rotatable Bonds:  6
TPSA:  131.88
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.547
Synthetic Accessibility Score:  4.993
Fsp3:  0.724
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.378
MDCK Permeability:  2.3056021746015176e-05
Pgp-inhibitor:  0.641
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.013
20% Bioavailability (F20%):  0.229
30% Bioavailability (F30%):  0.945

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.353
Plasma Protein Binding (PPB):  79.38726043701172%
Volume Distribution (VD):  0.296
Pgp-substrate:  17.194887161254883%

ADMET: Metabolism

CYP1A2-inhibitor:  0.003
CYP1A2-substrate:  0.497
CYP2C19-inhibitor:  0.026
CYP2C19-substrate:  0.833
CYP2C9-inhibitor:  0.084
CYP2C9-substrate:  0.928
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.074
CYP3A4-inhibitor:  0.087
CYP3A4-substrate:  0.517

ADMET: Excretion

Clearance (CL):  3.613
Half-life (T1/2):  0.852

ADMET: Toxicity

hERG Blockers:  0.001
Human Hepatotoxicity (H-HT):  0.154
Drug-inuced Liver Injury (DILI):  0.309
AMES Toxicity:  0.073
Rat Oral Acute Toxicity:  0.062
Maximum Recommended Daily Dose:  0.25
Skin Sensitization:  0.094
Carcinogencity:  0.045
Eye Corrosion:  0.018
Eye Irritation:  0.025
Respiratory Toxicity:  0.422

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC124211

Natural Product ID:  NPC124211
Common Name*:   Lucidenic Acid D2
IUPAC Name:   (4R)-4-[(5R,10S,12S,13R,14R,17R)-12-acetyloxy-4,4,10,13,14-pentamethyl-3,7,11,15-tetraoxo-2,5,6,12,16,17-hexahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
Synonyms:   Lucidenic Acid D2
Standard InCHIKey:  LTJSBYAKDOGXLX-JTJCPSTFSA-N
Standard InCHI:  InChI=1S/C29H38O8/c1-14(8-9-21(34)35)16-12-20(33)29(7)22-17(31)13-18-26(3,4)19(32)10-11-27(18,5)23(22)24(36)25(28(16,29)6)37-15(2)30/h14,16,18,25H,8-13H2,1-7H3,(H,34,35)/p-1/t14-,16-,18+,25-,27+,28+,29+/m1/s1
SMILES:  C[C@H](CCC(=O)[O-])[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)[C@H]([C@]12C)OC(=O)C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1CC3=O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL518100
PubChem CID:   23247891
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. DOI[10.1016/j.phytochem.2005.10.025]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[11520245]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[12045343]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[14695801]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[1791484]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. spore n.a. PMID[18827358]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies Nagano, Japan 2008-MAY PMID[20039640]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[20384295]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies n.a. n.a. PMID[20702092]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting bodies n.a. n.a. PMID[21924611]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[22014750]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[22044278]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota fruiting body n.a. n.a. PMID[22047696]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. PMID[26222905]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. fruit body n.a. PMID[9635497]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO16609 Ganoderma sinense Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO25269 Ganoderma lucidum Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16609 Ganoderma sinense Species Ganodermataceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Activity = 70.0 % PMID[508830]
NPT2 Others Unspecified Activity = 2.0 % PMID[508830]
NPT2 Others Unspecified Activity = 26.1 % PMID[508830]
NPT2 Others Unspecified Activity = 73.8 % PMID[508830]
NPT2 Others Unspecified Activity = 96.1 % PMID[508830]
NPT2 Others Unspecified IC50 = 287.0 molar ratio PMID[508830]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC124211 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9894 High Similarity NPC53222
0.9789 High Similarity NPC33973
0.9789 High Similarity NPC70967
0.9688 High Similarity NPC135854
0.9688 High Similarity NPC2436
0.9688 High Similarity NPC216245
0.9688 High Similarity NPC470251
0.9677 High Similarity NPC216904
0.9574 High Similarity NPC275439
0.9574 High Similarity NPC112753
0.9474 High Similarity NPC88198
0.9474 High Similarity NPC157787
0.9118 High Similarity NPC115303
0.9109 High Similarity NPC286174
0.9109 High Similarity NPC77947
0.9062 High Similarity NPC43747
0.9053 High Similarity NPC255809
0.902 High Similarity NPC129689
0.9 High Similarity NPC51452
0.8958 High Similarity NPC125622
0.8942 High Similarity NPC472929
0.8854 High Similarity NPC241156
0.8824 High Similarity NPC295244
0.88 High Similarity NPC251017
0.8763 High Similarity NPC305483
0.8763 High Similarity NPC95565
0.8763 High Similarity NPC96859
0.8763 High Similarity NPC328162
0.8673 High Similarity NPC23680
0.8673 High Similarity NPC106557
0.8673 High Similarity NPC121339
0.866 High Similarity NPC470016
0.866 High Similarity NPC317586
0.8654 High Similarity NPC473036
0.8654 High Similarity NPC272898
0.8646 High Similarity NPC25750
0.8571 High Similarity NPC243525
0.8571 High Similarity NPC3772
0.8571 High Similarity NPC40765
0.8557 High Similarity NPC166906
0.8557 High Similarity NPC477439
0.8544 High Similarity NPC473037
0.8519 High Similarity NPC472927
0.8519 High Similarity NPC472934
0.8515 High Similarity NPC281702
0.85 High Similarity NPC144660
0.85 High Similarity NPC299971
0.85 High Similarity NPC307954
0.8495 Intermediate Similarity NPC473038
0.8469 Intermediate Similarity NPC477438
0.8469 Intermediate Similarity NPC37646
0.8469 Intermediate Similarity NPC477437
0.84 Intermediate Similarity NPC16021
0.8396 Intermediate Similarity NPC472928
0.8387 Intermediate Similarity NPC209882
0.8367 Intermediate Similarity NPC184870
0.8364 Intermediate Similarity NPC472933
0.835 Intermediate Similarity NPC28656
0.8333 Intermediate Similarity NPC308726
0.8333 Intermediate Similarity NPC56498
0.8333 Intermediate Similarity NPC119601
0.8333 Intermediate Similarity NPC473039
0.8318 Intermediate Similarity NPC264634
0.8318 Intermediate Similarity NPC147180
0.8317 Intermediate Similarity NPC316964
0.8317 Intermediate Similarity NPC205899
0.8317 Intermediate Similarity NPC51370
0.83 Intermediate Similarity NPC226986
0.83 Intermediate Similarity NPC122294
0.8283 Intermediate Similarity NPC473648
0.828 Intermediate Similarity NPC469561
0.828 Intermediate Similarity NPC271784
0.8265 Intermediate Similarity NPC470254
0.8265 Intermediate Similarity NPC477435
0.8265 Intermediate Similarity NPC477436
0.8252 Intermediate Similarity NPC55872
0.8247 Intermediate Similarity NPC20388
0.8241 Intermediate Similarity NPC472926
0.8235 Intermediate Similarity NPC473514
0.8235 Intermediate Similarity NPC302537
0.8235 Intermediate Similarity NPC163372
0.8218 Intermediate Similarity NPC10364
0.82 Intermediate Similarity NPC7124
0.82 Intermediate Similarity NPC328371
0.8163 Intermediate Similarity NPC26888
0.8163 Intermediate Similarity NPC107690
0.8163 Intermediate Similarity NPC297265
0.8155 Intermediate Similarity NPC80781
0.8155 Intermediate Similarity NPC234892
0.8144 Intermediate Similarity NPC474889
0.8137 Intermediate Similarity NPC327431
0.8137 Intermediate Similarity NPC476274
0.8137 Intermediate Similarity NPC287833
0.8131 Intermediate Similarity NPC470496
0.8119 Intermediate Similarity NPC18319
0.8105 Intermediate Similarity NPC123319
0.8105 Intermediate Similarity NPC94531
0.8105 Intermediate Similarity NPC311702
0.81 Intermediate Similarity NPC174948
0.81 Intermediate Similarity NPC173875
0.81 Intermediate Similarity NPC469995
0.81 Intermediate Similarity NPC318282
0.81 Intermediate Similarity NPC297199
0.81 Intermediate Similarity NPC469599
0.8095 Intermediate Similarity NPC475494
0.8095 Intermediate Similarity NPC181357
0.8091 Intermediate Similarity NPC270958
0.8077 Intermediate Similarity NPC275583
0.8077 Intermediate Similarity NPC236390
0.8073 Intermediate Similarity NPC202889
0.8061 Intermediate Similarity NPC111585
0.8061 Intermediate Similarity NPC148414
0.8061 Intermediate Similarity NPC175628
0.8058 Intermediate Similarity NPC476240
0.8058 Intermediate Similarity NPC476223
0.8058 Intermediate Similarity NPC224720
0.8056 Intermediate Similarity NPC43775
0.8056 Intermediate Similarity NPC34315
0.8041 Intermediate Similarity NPC185059
0.8041 Intermediate Similarity NPC475001
0.8041 Intermediate Similarity NPC242864
0.8041 Intermediate Similarity NPC143767
0.8041 Intermediate Similarity NPC131470
0.8037 Intermediate Similarity NPC304495
0.802 Intermediate Similarity NPC42042
0.802 Intermediate Similarity NPC192428
0.8019 Intermediate Similarity NPC475294
0.8019 Intermediate Similarity NPC220974
0.8019 Intermediate Similarity NPC472925
0.8019 Intermediate Similarity NPC44063
0.8 Intermediate Similarity NPC159410
0.8 Intermediate Similarity NPC109512
0.8 Intermediate Similarity NPC235889
0.8 Intermediate Similarity NPC320801
0.8 Intermediate Similarity NPC96268
0.7982 Intermediate Similarity NPC71348
0.7982 Intermediate Similarity NPC285956
0.7982 Intermediate Similarity NPC221144
0.7982 Intermediate Similarity NPC100267
0.7982 Intermediate Similarity NPC170487
0.7982 Intermediate Similarity NPC475524
0.7981 Intermediate Similarity NPC195290
0.7981 Intermediate Similarity NPC204450
0.7981 Intermediate Similarity NPC475558
0.7981 Intermediate Similarity NPC136289
0.7981 Intermediate Similarity NPC163249
0.7981 Intermediate Similarity NPC473788
0.7981 Intermediate Similarity NPC293753
0.798 Intermediate Similarity NPC168027
0.798 Intermediate Similarity NPC248913
0.798 Intermediate Similarity NPC150383
0.798 Intermediate Similarity NPC185936
0.7961 Intermediate Similarity NPC472972
0.7959 Intermediate Similarity NPC275740
0.7959 Intermediate Similarity NPC86319
0.7946 Intermediate Similarity NPC118638
0.7941 Intermediate Similarity NPC320306
0.7941 Intermediate Similarity NPC292133
0.7938 Intermediate Similarity NPC99909
0.7925 Intermediate Similarity NPC196528
0.7925 Intermediate Similarity NPC181265
0.7921 Intermediate Similarity NPC200702
0.7921 Intermediate Similarity NPC184848
0.7921 Intermediate Similarity NPC69548
0.7921 Intermediate Similarity NPC48330
0.7917 Intermediate Similarity NPC11711
0.7917 Intermediate Similarity NPC90287
0.7905 Intermediate Similarity NPC159442
0.7905 Intermediate Similarity NPC264048
0.79 Intermediate Similarity NPC79117
0.79 Intermediate Similarity NPC109414
0.79 Intermediate Similarity NPC170220
0.79 Intermediate Similarity NPC206810
0.79 Intermediate Similarity NPC107674
0.79 Intermediate Similarity NPC141497
0.7895 Intermediate Similarity NPC168188
0.7895 Intermediate Similarity NPC470015
0.789 Intermediate Similarity NPC231589
0.789 Intermediate Similarity NPC118860
0.789 Intermediate Similarity NPC214797
0.7885 Intermediate Similarity NPC81530
0.7879 Intermediate Similarity NPC289213
0.7879 Intermediate Similarity NPC183283
0.7879 Intermediate Similarity NPC471896
0.787 Intermediate Similarity NPC241927
0.787 Intermediate Similarity NPC250018
0.787 Intermediate Similarity NPC2766
0.787 Intermediate Similarity NPC258543
0.7864 Intermediate Similarity NPC114274
0.7864 Intermediate Similarity NPC197386
0.7864 Intermediate Similarity NPC147954
0.7857 Intermediate Similarity NPC471722
0.7857 Intermediate Similarity NPC471854
0.7843 Intermediate Similarity NPC120708
0.7843 Intermediate Similarity NPC173272
0.7843 Intermediate Similarity NPC472941
0.7843 Intermediate Similarity NPC456
0.7835 Intermediate Similarity NPC28252
0.7835 Intermediate Similarity NPC55309
0.7835 Intermediate Similarity NPC229717

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC124211 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8558 High Similarity NPD6373 Approved
0.8558 High Similarity NPD6372 Approved
0.8396 Intermediate Similarity NPD6649 Approved
0.8396 Intermediate Similarity NPD6650 Approved
0.8269 Intermediate Similarity NPD6675 Approved
0.8269 Intermediate Similarity NPD7128 Approved
0.8269 Intermediate Similarity NPD5739 Approved
0.8269 Intermediate Similarity NPD6402 Approved
0.8265 Intermediate Similarity NPD6399 Phase 3
0.8218 Intermediate Similarity NPD5696 Approved
0.8113 Intermediate Similarity NPD6881 Approved
0.8113 Intermediate Similarity NPD7320 Approved
0.8113 Intermediate Similarity NPD6899 Approved
0.81 Intermediate Similarity NPD5695 Phase 3
0.8041 Intermediate Similarity NPD6672 Approved
0.8041 Intermediate Similarity NPD5737 Approved
0.802 Intermediate Similarity NPD4697 Phase 3
0.8019 Intermediate Similarity NPD5701 Approved
0.8019 Intermediate Similarity NPD5697 Approved
0.7982 Intermediate Similarity NPD8297 Approved
0.7982 Intermediate Similarity NPD6882 Approved
0.7963 Intermediate Similarity NPD7102 Approved
0.7963 Intermediate Similarity NPD6883 Approved
0.7963 Intermediate Similarity NPD7290 Approved
0.7944 Intermediate Similarity NPD6011 Approved
0.7941 Intermediate Similarity NPD6084 Phase 2
0.7941 Intermediate Similarity NPD6083 Phase 2
0.789 Intermediate Similarity NPD6617 Approved
0.789 Intermediate Similarity NPD6869 Approved
0.789 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.789 Intermediate Similarity NPD8130 Phase 1
0.789 Intermediate Similarity NPD6847 Approved
0.787 Intermediate Similarity NPD6013 Approved
0.787 Intermediate Similarity NPD6012 Approved
0.787 Intermediate Similarity NPD6014 Approved
0.7778 Intermediate Similarity NPD5328 Approved
0.767 Intermediate Similarity NPD5221 Approved
0.767 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.767 Intermediate Similarity NPD5222 Approved
0.7624 Intermediate Similarity NPD6050 Approved
0.7624 Intermediate Similarity NPD6079 Approved
0.7611 Intermediate Similarity NPD6868 Approved
0.76 Intermediate Similarity NPD6904 Approved
0.76 Intermediate Similarity NPD6080 Approved
0.76 Intermediate Similarity NPD6673 Approved
0.7596 Intermediate Similarity NPD4755 Approved
0.7596 Intermediate Similarity NPD5173 Approved
0.7596 Intermediate Similarity NPD7902 Approved
0.7525 Intermediate Similarity NPD5692 Phase 3
0.7478 Intermediate Similarity NPD6335 Approved
0.7476 Intermediate Similarity NPD7748 Approved
0.7475 Intermediate Similarity NPD7146 Approved
0.7475 Intermediate Similarity NPD5279 Phase 3
0.7475 Intermediate Similarity NPD7521 Approved
0.7475 Intermediate Similarity NPD7334 Approved
0.7475 Intermediate Similarity NPD6409 Approved
0.7475 Intermediate Similarity NPD3618 Phase 1
0.7475 Intermediate Similarity NPD6684 Approved
0.7475 Intermediate Similarity NPD5330 Approved
0.7456 Intermediate Similarity NPD6274 Approved
0.7453 Intermediate Similarity NPD5285 Approved
0.7453 Intermediate Similarity NPD5286 Approved
0.7453 Intermediate Similarity NPD4700 Approved
0.7453 Intermediate Similarity NPD4696 Approved
0.7451 Intermediate Similarity NPD8035 Phase 2
0.7451 Intermediate Similarity NPD8034 Phase 2
0.7451 Intermediate Similarity NPD5694 Approved
0.7449 Intermediate Similarity NPD4786 Approved
0.7431 Intermediate Similarity NPD6008 Approved
0.7414 Intermediate Similarity NPD7101 Approved
0.7414 Intermediate Similarity NPD7100 Approved
0.7404 Intermediate Similarity NPD5210 Approved
0.7404 Intermediate Similarity NPD4629 Approved
0.7391 Intermediate Similarity NPD6317 Approved
0.7383 Intermediate Similarity NPD5223 Approved
0.7368 Intermediate Similarity NPD3617 Approved
0.735 Intermediate Similarity NPD6319 Approved
0.7328 Intermediate Similarity NPD6313 Approved
0.7328 Intermediate Similarity NPD6314 Approved
0.7327 Intermediate Similarity NPD6903 Approved
0.7327 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD5226 Approved
0.7315 Intermediate Similarity NPD5225 Approved
0.7315 Intermediate Similarity NPD4633 Approved
0.7315 Intermediate Similarity NPD5224 Approved
0.7315 Intermediate Similarity NPD5211 Phase 2
0.7308 Intermediate Similarity NPD7900 Approved
0.7308 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD6098 Approved
0.7288 Intermediate Similarity NPD6908 Approved
0.7288 Intermediate Similarity NPD6909 Approved
0.7282 Intermediate Similarity NPD5281 Approved
0.7282 Intermediate Similarity NPD7515 Phase 2
0.7282 Intermediate Similarity NPD5693 Phase 1
0.7282 Intermediate Similarity NPD5284 Approved
0.7281 Intermediate Similarity NPD4632 Approved
0.7273 Intermediate Similarity NPD4767 Approved
0.7273 Intermediate Similarity NPD4768 Approved
0.7255 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD4753 Phase 2
0.7248 Intermediate Similarity NPD5175 Approved
0.7248 Intermediate Similarity NPD4754 Approved
0.7248 Intermediate Similarity NPD5174 Approved
0.7245 Intermediate Similarity NPD3667 Approved
0.7241 Intermediate Similarity NPD6009 Approved
0.7238 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD5654 Approved
0.72 Intermediate Similarity NPD5329 Approved
0.7182 Intermediate Similarity NPD5141 Approved
0.7167 Intermediate Similarity NPD7604 Phase 2
0.7143 Intermediate Similarity NPD4730 Approved
0.7143 Intermediate Similarity NPD5983 Phase 2
0.7143 Intermediate Similarity NPD4729 Approved
0.7143 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD4694 Approved
0.7129 Intermediate Similarity NPD5690 Phase 2
0.7129 Intermediate Similarity NPD5280 Approved
0.7115 Intermediate Similarity NPD6411 Approved
0.7107 Intermediate Similarity NPD7492 Approved
0.7103 Intermediate Similarity NPD5959 Approved
0.71 Intermediate Similarity NPD4197 Approved
0.71 Intermediate Similarity NPD3665 Phase 1
0.71 Intermediate Similarity NPD3133 Approved
0.71 Intermediate Similarity NPD3666 Approved
0.7094 Intermediate Similarity NPD7115 Discovery
0.7059 Intermediate Similarity NPD6059 Approved
0.7059 Intermediate Similarity NPD6054 Approved
0.7054 Intermediate Similarity NPD6614 Approved
0.7049 Intermediate Similarity NPD6336 Discontinued
0.7049 Intermediate Similarity NPD6616 Approved
0.7048 Intermediate Similarity NPD4202 Approved
0.7037 Intermediate Similarity NPD7638 Approved
0.703 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD5207 Approved
0.7018 Intermediate Similarity NPD5249 Phase 3
0.7018 Intermediate Similarity NPD5250 Approved
0.7018 Intermediate Similarity NPD5251 Approved
0.7018 Intermediate Similarity NPD5247 Approved
0.7018 Intermediate Similarity NPD5248 Approved
0.6992 Remote Similarity NPD7078 Approved
0.6992 Remote Similarity NPD8293 Discontinued
0.6991 Remote Similarity NPD5168 Approved
0.6991 Remote Similarity NPD5128 Approved
0.6972 Remote Similarity NPD7640 Approved
0.6972 Remote Similarity NPD7639 Approved
0.6961 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6949 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6942 Remote Similarity NPD6370 Approved
0.6935 Remote Similarity NPD7736 Approved
0.6931 Remote Similarity NPD3668 Phase 3
0.693 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6101 Approved
0.6923 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7260 Phase 2
0.69 Remote Similarity NPD4221 Approved
0.69 Remote Similarity NPD4223 Phase 3
0.6893 Remote Similarity NPD3573 Approved
0.6885 Remote Similarity NPD8328 Phase 3
0.687 Remote Similarity NPD5135 Approved
0.687 Remote Similarity NPD4634 Approved
0.687 Remote Similarity NPD5169 Approved
0.687 Remote Similarity NPD5134 Clinical (unspecified phase)
0.687 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6869 Remote Similarity NPD4695 Discontinued
0.686 Remote Similarity NPD6015 Approved
0.686 Remote Similarity NPD6016 Approved
0.6852 Remote Similarity NPD7614 Phase 1
0.685 Remote Similarity NPD6845 Suspended
0.6847 Remote Similarity NPD7632 Discontinued
0.6827 Remote Similarity NPD5208 Approved
0.6822 Remote Similarity NPD6001 Approved
0.681 Remote Similarity NPD5217 Approved
0.681 Remote Similarity NPD5215 Approved
0.681 Remote Similarity NPD5216 Approved
0.681 Remote Similarity NPD5127 Approved
0.6804 Remote Similarity NPD6117 Approved
0.6803 Remote Similarity NPD5988 Approved
0.68 Remote Similarity NPD4692 Approved
0.68 Remote Similarity NPD4139 Approved
0.6771 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6737 Remote Similarity NPD6081 Approved
0.6735 Remote Similarity NPD6116 Phase 1
0.6729 Remote Similarity NPD5133 Approved
0.6699 Remote Similarity NPD1694 Approved
0.6697 Remote Similarity NPD7732 Phase 3
0.6696 Remote Similarity NPD5091 Approved
0.6667 Remote Similarity NPD6115 Approved
0.6667 Remote Similarity NPD6697 Approved
0.6667 Remote Similarity NPD6033 Approved
0.6667 Remote Similarity NPD6118 Approved
0.6667 Remote Similarity NPD6114 Approved
0.6639 Remote Similarity NPD5167 Approved
0.6635 Remote Similarity NPD4689 Approved
0.6635 Remote Similarity NPD4138 Approved
0.6635 Remote Similarity NPD4688 Approved
0.6635 Remote Similarity NPD4690 Approved
0.6635 Remote Similarity NPD4693 Phase 3
0.6635 Remote Similarity NPD5205 Approved
0.661 Remote Similarity NPD6053 Discontinued
0.6609 Remote Similarity NPD6412 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data